As of January 22, 2025, Day One Biopharmaceuticals (DAWN) has a market cap of $1.25 billion USD. According to our data, Day One Biopharmaceuticals is ranked No.4875 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $1.25 B |
-2.29%
|
Dec 31, 2024 | $1.28 B |
-13.22%
|
Dec 29, 2023 | $1.47 B |
-32.16%
|
Dec 30, 2022 | $2.17 B |
27.72%
|
Dec 31, 2021 | $1.70 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
USA
|
Kura Oncology
KURA
|
$0.61 B |
0.000 M
|
USA
|
Zymeworks
ZYME
|
$1.01 B |
-0.000 M
|
Canada
|
Relay Therapeutics
RLAY
|
$0.82 B |
0.000 M
|
USA
|
Revolution Medicines
RVMD
|
$7.56 B |
0.000 M
|
USA
|
Cogent Biosciences
COGT
|
$0.91 B |
-0.000 M
|
USA
|
Foghorn Therapeutics
FHTX
|
$0.24 B |
0.000 M
|
USA
|
Erasca
ERAS
|
$0.55 B |
-0.000 M
|
USA
|
Market Cap | = | DAWN Stock Price | * | DAWN Shares Outstanding |
= | $12.38 | * | 0.10 B | |
= | $1.25 B |